中国血王之战

华尔街见闻
Jun 12, 2025

血制品企业派林生物(000403.SZ)控制权接盘方终于浮出水面。 6月10日,派林生物宣布控股股东共青城胜帮英豪投资合伙企业(有限合伙)计划将持有的全部股份(21.03%)转让给中国生物技术股份有限公司(下称“中国生物”)。 中国生物控股派林生物也意味着,后者的实控人将从陕西国资变为国药集团。 不过中国生物还控制着血制品公司天坛生物(600161.SH),这导致其与派林生物构成同业竞争。 市场...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10